Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2005-01-07
2010-10-05
Channavajjala, Lakshmi S (Department: 1611)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C424S456000, C424S457000
Reexamination Certificate
active
07807195
ABSTRACT:
The present invention relates to an extended release once daily pharmaceutical formulation comprising venlafaxine hydrochloride and pharmaceutically acceptable excipients. More particularly, the present invention relates to an extended release composition in the form of mini-tablets which are incorporated in hard gelatin capsules.
REFERENCES:
patent: 4153677 (1979-05-01), John
patent: 4535186 (1985-08-01), Husbands
patent: 6274171 (2001-08-01), Sherman
patent: 6346269 (2002-02-01), Hsiao et al.
patent: 6696496 (2004-02-01), Oosterbaan et al.
patent: 6703044 (2004-03-01), Pinhasi et al.
patent: 7309719 (2007-12-01), Aomatsu
patent: 2002/0155156 (2002-10-01), Mulye
patent: 2003/0133982 (2003-07-01), Heimlich et al.
patent: 2003/0190354 (2003-10-01), Sela
patent: 2004/0096501 (2004-05-01), Vaya
patent: 2006/0257482 (2006-11-01), Kumar et al.
patent: 0797991 (1997-10-01), None
patent: WO 94/27589 (1994-12-01), None
patent: WO 99/22724 (1999-05-01), None
patent: WO 01/37815 (2001-05-01), None
patent: WO 03/053402 (2003-07-01), None
patent: WO 03/055475 (2003-07-01), None
patent: WO 2004/012699 (2004-02-01), None
Bhattacharya Sampad
Joshi Mayank
Kshirsagar Rajesh
Pandita Sandeep
Akerman & Senterfitt
Alembic Limited
Channavajjala Lakshmi S
Chiabotti Peter A.
Welter Rachael E
LandOfFree
Extended release formulation of venlafaxine hydrochloride does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extended release formulation of venlafaxine hydrochloride, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended release formulation of venlafaxine hydrochloride will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4232896